PMI
Picard Medical, Inc. (AMEX)
Healthcare — Medical Devices
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
None
$0.17
+$0.01 (+4.88%)
Sign in to add PMI to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $17.68M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.91 |
| EPS (TTM) | $-0.76 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 85.50% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 39.3 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $13.68 |
| 52-Week Low | $0.11 |
| 50-Day Avg | $0.28 |
| 200-Day Avg | $2.55 |
| Avg Volume | $29.67M |
| Volume | $16.60M |
Performance Analysis
NEUTRALPMI presents a mixed picture with both positive and negative indicators.
+
Trading near its 52-week low ($0.11), which could present a value opportunity.
~
RSI at 39.3 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
+
Strong revenue growth of 85.5% year-over-year.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:26 UTC
Back to Screener Export Report